Latest Insider Transactions at Vir Biotechnology, Inc. (VIR)
This section provides a real-time view of insider transactions for Vir Biotechnology, Inc. (VIR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vir Biotechnology, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vir Biotechnology, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
57,248
-0.17%
|
$1,488,448
$26.08 P/Share
|
|
Jun 13
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
106,854
-0.31%
|
$2,885,058
$27.02 P/Share
|
|
Jun 07
2023
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.59%
|
$125,000
$25.95 P/Share
|
|
Jun 07
2023
|
Phillip Pang EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.53%
|
$5,000
$1.53 P/Share
|
|
Jun 05
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,197
-0.03%
|
$140,319
$27.32 P/Share
|
|
Jun 02
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
34,365
-0.2%
|
$927,855
$27.32 P/Share
|
|
Jun 01
2023
|
Saira Ramasastry Director |
SELL
Open market or private sale
|
Direct |
3,500
-24.79%
|
$87,500
$25.67 P/Share
|
|
Jun 01
2023
|
Steven J. Rice Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
2,500
-2.29%
|
$62,500
$25.67 P/Share
|
|
May 24
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
104,384
-0.2%
|
$2,713,984
$26.42 P/Share
|
|
May 23
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
170,067
-0.33%
|
$4,421,742
$26.49 P/Share
|
|
May 22
2023
|
Robert Nelsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,027
+1.04%
|
-
|
|
May 22
2023
|
Robert J Perez Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,027
+27.61%
|
-
|
|
May 22
2023
|
Robert J More Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,027
+11.79%
|
-
|
|
May 22
2023
|
Janet Napolitano Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,027
+27.61%
|
-
|
|
May 22
2023
|
Saira Ramasastry Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,027
+29.92%
|
-
|
|
May 22
2023
|
Phillip A Sharp Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,027
+4.74%
|
-
|
|
May 22
2023
|
Vicki L Sato Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,027
+0.45%
|
-
|
|
May 22
2023
|
Charles Elliott Sigal Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,027
+27.61%
|
-
|
|
May 22
2023
|
Jeffrey S. Hatfield Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,027
+27.61%
|
-
|
|
May 22
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
91,896
-0.52%
|
$2,297,400
$25.72 P/Share
|
|
May 19
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
91,651
-0.52%
|
$2,291,275
$25.38 P/Share
|
|
May 05
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
136
-0.0%
|
$3,400
$25.1 P/Share
|
|
May 04
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
114,332
-0.64%
|
$2,858,300
$25.55 P/Share
|
|
May 03
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
83,674
-0.47%
|
$2,091,850
$25.51 P/Share
|
|
May 01
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,075
-0.02%
|
$76,875
$25.3 P/Share
|
|
Apr 25
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
961
-0.01%
|
$24,025
$25.3 P/Share
|
|
Apr 24
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
66,038
-0.37%
|
$1,650,950
$25.42 P/Share
|
|
Apr 21
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
305,393
-0.84%
|
$7,634,825
$25.89 P/Share
|
|
Apr 20
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,590
-0.04%
|
$164,750
$25.06 P/Share
|
|
Apr 19
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
76,114
-0.42%
|
$1,902,850
$25.12 P/Share
|
|
Apr 18
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,953
-0.04%
|
$173,825
$25.12 P/Share
|
|
Apr 17
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,524
-0.06%
|
$263,100
$25.06 P/Share
|
|
Apr 14
2023
|
Svf Endurance (Cayman) LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
9,565
-0.05%
|
$239,125
$25.11 P/Share
|
|
Apr 03
2023
|
Marianne De Backer Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
576,452
+50.0%
|
-
|
|
Mar 30
2023
|
Ann M. Hanly EVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,627
-2.24%
|
$57,794
$22.77 P/Share
|
|
Mar 27
2023
|
Sung Lee EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,500
+50.0%
|
-
|
|
Mar 08
2023
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
17,935
-1.33%
|
$394,570
$22.59 P/Share
|
|
Mar 03
2023
|
Johanna Friedl Naderer EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,482
-0.99%
|
$32,604
$22.82 P/Share
|
|
Mar 01
2023
|
Charles Elliott Sigal Director |
BUY
Open market or private purchase
|
Indirect |
2,500
+20.0%
|
$55,000
$22.73 P/Share
|
|
Feb 27
2023
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,320
-2.62%
|
$237,360
$23.28 P/Share
|
|
Feb 24
2023
|
George A Scangos Director |
SELL
Open market or private sale
|
Direct |
15,119
-4.19%
|
$347,737
$23.15 P/Share
|
|
Feb 23
2023
|
Ann M. Hanly EVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,302
-1.93%
|
$57,550
$25.97 P/Share
|
|
Feb 23
2023
|
Howard Horn CFO |
SELL
Open market or private sale
|
Direct |
2,248
-0.97%
|
$56,200
$25.97 P/Share
|
|
Feb 23
2023
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,878
-1.43%
|
$71,950
$25.97 P/Share
|
|
Feb 23
2023
|
George A Scangos Director |
SELL
Open market or private sale
|
Direct |
12,631
-6.44%
|
$315,775
$25.97 P/Share
|
|
Feb 23
2023
|
Steven J. Rice Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,795
-1.63%
|
$44,875
$25.97 P/Share
|
|
Feb 22
2023
|
Ann M. Hanly EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+23.88%
|
-
|
|
Feb 22
2023
|
Phillip Pang EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+22.97%
|
-
|
|
Feb 22
2023
|
Johanna Friedl Naderer EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+28.57%
|
-
|
|
Feb 22
2023
|
Steven J. Rice Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,000
+39.85%
|
-
|